Screening for functional neurological disorders by questionnaire.

Functional neurological disorders Neurological symptoms Neuropsychiatry Screening questionnaire Symptom count

Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
04 2019
Historique:
received: 28 09 2018
revised: 12 01 2019
accepted: 10 02 2019
entrez: 6 4 2019
pubmed: 6 4 2019
medline: 26 2 2020
Statut: ppublish

Résumé

Diagnostic screening for functional neurological disorders (FNDs) continues to pose a challenge. Simple symptom counts fail clearly to discriminate patients with FND but there is increasing recognition of 'positive' features which are useful diagnostically during face-to-face assessments. A self-completed questionnaire evaluating specific features of FNDs would be useful for screening purposes in clinical and research settings. The Edinburgh Neurosymptoms Questionnaire (ENS) is a 30-item survey of presence and nature of: blackouts, weakness, hemisensory syndrome, memory problems, tremor, pain, fatigue, globus, multiple medical problems, and operations constructed via literature review and expert consensus. We conducted a pilot of the ENS on new general neurology clinic attendees at a large regional neuroscience centre. Patients were grouped according to consultant neurologist impression as having symptoms that were 'Not at all', 'Somewhat', 'Largely' or 'Completely' due to a functional disorder. Blackouts, weakness and memory questions provided reasonable diagnostic utility (AUROC = 0.94, 0.71, 0.74 respectively) in single symptom analysis. All other symptoms lacked discriminating features. A multivariate linear model with all symptoms predicted functional classification with moderate diagnostic utility (AUROC = 0.83), specificity of 0.97, sensitivity of 0.47. Pain and blackout scores provided the most accurate predictor of functional classification. The ENS questionnaire provides some utility in differentiating patients presenting with functional blackouts but failed to provide diagnostic value in other types of FND, highlighting the limitations of this self-report tool.

Identifiants

pubmed: 30947820
pii: S0022-3999(18)30837-7
doi: 10.1016/j.jpsychores.2019.02.005
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-73

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Oliver Shipston-Sharman (O)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Ingrid Hoeritzauer (I)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Mark Edwards (M)

Neuroscience Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom.

Markus Reuber (M)

Academic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, United Kingdom.

Alan Carson (A)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom; Scottish Neurobehavioural Rehabilitation Unit, Royal Edinburgh Hospital, Edinburgh, United Kingdom.

Jon Stone (J)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: Jon.Stone@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH